Pay in 4 interest-free payments of $6.89 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Intestinal microbiota, diet and health
The National Institute on Drug Abuse is sponsoring a clinical trial this year evaluating tirzepatide, the active ingredient in Eli Lillys weight-loss drugs, as a potential treatment for cannabis use disorder
Jen : Thats a great point
Singer , Senior Fellow, Cato Institute Tracy Zvenyach , Director, Policy Strategy & Alliances, Obesity Action Coalition 3:50 | Audience Q&A 4:25 | Closing Remarks 4:30 | Adjourn Health in the Headlines This event is part of the National Academy of Medicines Health in the Headlines series, which investigates high-profile health and health policy topics making the news
THIS SITE DOES NOT PROVIDE MEDICAL OR HEALTH CARE ADVICE
